BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8725161)

  • 21. Lipolysis is a prerequisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic very low density lipoproteins.
    Evans AJ; Sawyez CG; Wolfe BM; Huff MW
    J Biol Chem; 1992 May; 267(15):10743-51. PubMed ID: 1587849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of synthetic peptide analogs of the amphipathic helix. Correlation of structure with function.
    Chung BH; Anatharamaiah GM; Brouillette CG; Nishida T; Segrest JP
    J Biol Chem; 1985 Aug; 260(18):10256-62. PubMed ID: 4019511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
    Aalto-Setälä K; Fisher EA; Chen X; Chajek-Shaul T; Hayek T; Zechner R; Walsh A; Ramakrishnan R; Ginsberg HN; Breslow JL
    J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of model class A1, class A2, and class Y amphipathic helical peptides with membranes.
    Mishra VK; Palgunachari MN
    Biochemistry; 1996 Aug; 35(34):11210-20. PubMed ID: 8780526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of a model class A (apolipoprotein) amphipathic alpha helical peptide with lipid: high resolution NMR studies of peptide.lipid discoidal complexes.
    Mishra VK; Anantharamaiah GM; Segrest JP; Palgunachari MN; Chaddha M; Sham SW; Krishna NR
    J Biol Chem; 2006 Mar; 281(10):6511-9. PubMed ID: 16407255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipolytic remnants of human VLDL produced in vitro. Effect of HDL levels in the lipolysis mixtures on the apoCs to apoE ratio and metabolic properties of VLDL core remnants.
    Chung BH; Dashti N
    J Lipid Res; 2000 Feb; 41(2):285-97. PubMed ID: 10681413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.
    Medh JD; Fry GL; Bowen SL; Ruben S; Wong H; Chappell DA
    J Lipid Res; 2000 Nov; 41(11):1858-71. PubMed ID: 11060356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipolysis-induced degradation of apolipoproteins B and E of human very low density lipoproteins.
    Chung BH; Im JH; Bowdon HR
    J Biol Chem; 1986 Feb; 261(6):2960-7. PubMed ID: 3949755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
    Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA
    J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms.
    Evans AJ; Sawyez CG; Wolfe BM; Connelly PW; Maguire GF; Huff MW
    J Lipid Res; 1993 May; 34(5):703-17. PubMed ID: 8509711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topo-dynamic characteristics of human plasma VLDL apolipoproteins and efficiency of triacylglycerol hydrolysis by lipoprotein lipase.
    Dergunov AD; Shuvaev VV; Perova NV
    Biochim Biophys Acta; 1989 Sep; 1005(1):79-86. PubMed ID: 2775763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of lipoprotein lipase to apolipoprotein B-containing lipoproteins.
    Carrero P; Gómez-Coronado D; Olivecrona G; Lasunción MA
    Biochim Biophys Acta; 1996 Jan; 1299(2):198-206. PubMed ID: 8555265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E and lipoprotein lipase reduce macrophage degradation of oxidized very-low-density lipoprotein (VLDL), but increase cellular degradation of native VLDL.
    Keidar S; Kaplan M; Rosenblat M; Brook GJ; Aviram M
    Metabolism; 1992 Nov; 41(11):1185-92. PubMed ID: 1435289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages.
    Lindqvist P; Ostlund-Lindqvist AM; Witztum JL; Steinberg D; Little JA
    J Biol Chem; 1983 Aug; 258(15):9086-92. PubMed ID: 6874679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
    van Barlingen HH; Kock LA; de Man FH; Erkelens DW; de Bruin TW
    Atherosclerosis; 1996 Mar; 121(1):75-84. PubMed ID: 8678926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase.
    Takahashi S; Suzuki J; Kohno M; Oida K; Tamai T; Miyabo S; Yamamoto T; Nakai T
    J Biol Chem; 1995 Jun; 270(26):15747-54. PubMed ID: 7797576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A.
    Sharifov OF; Nayyar G; Ternovoy VV; Palgunachari MN; Garber DW; Anantharamaiah G; Gupta H
    Innate Immun; 2014 Nov; 20(8):867-80. PubMed ID: 24323453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of very low density lipoproteins and intermediate density lipoproteins of normo- and hyperlipidemic apolipoprotein E-2 homozygotes.
    Schmitz G; Assmann G; Augustin J; Dirkes-Kersting A; Brennhaüsen B; Karoff C
    J Lipid Res; 1985 Mar; 26(3):316-26. PubMed ID: 3989390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of preferred binding domains on peptide retention behavior in reversed-phase chromatography: amphipathic alpha-helices.
    Zhou NE; Mant CT; Hodges RS
    Pept Res; 1990; 3(1):8-20. PubMed ID: 2134049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.